Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia

Cancer Science

Volumn 94, Issue 4, 2003, Pages 360-364

  Waki, Takayoshi ^a   Tamura, Gen ^a   Sato, Makoto ^a   Terashima, Masanori ^b   Nishizuka, Satoshi ^c   Motoyama, Teiichi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; MOLECULAR MARKER; PROTEIN KINASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; AUTOPSY; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; SAMPLE; STOMACH CANCER; STOMACH EPITHELIUM; STOMACH SURGERY; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CHILD; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; DNA, NEOPLASM; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; GASTRIC MUCOSA; HUMANS; INFANT; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS; SULFITES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0038527233     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01447.x     Document Type: Article

References (25)

1. Kass SU, Pruss D, Wolffe AP. How does DNA methylation repress transcription? Trends Genet 1997; 13: 444-9.
2. Razin A, Cedar H. DNA methylation and gene expression. Microbiol Rev 1991; 55: 451-8.
3. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 2: 163-7.
4. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225-9.
5. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y, Imai K. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 1999; 83: 309-13.
6. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000; 92: 569-73.
7. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou T, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG, Meltzer SJ. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999; 59: 1090-5.
8. Schneider BG, Gulley ML, Eagan P, Bravo JC, Mera R, Geradts J. Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach. Hum Pathol 2000; 31: 45-50.
9. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536-40.
10. Issa JP, Vertino PM, Boehm CD, Newsham IF, Baylin SB. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci USA 1996; 93: 11757-62.
11. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998; 58: 5489-94.
12. Issa JP. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 2000; 249: 101-18.
13. Endoh Y, Tamura G, Ajioka Y, Watanabe H, Motoyama T. Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype. Am J Pathol 2000; 157: 717-22.
14. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T. Promoter methylation status of E-cadherin, hMLH1 and p16 genes in non-neoplastic gastric epithelia. Am J Pathol 2002; 161: 399-403.
15. Cohen O, Kimichi A. DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Diff 2001; 8: 6-15.
16. Kissil JL, Feinstein E, Cohen O, Jones PA, Tsai YC, Knowles MA, Eydmann ME, Kimichi A. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell line: possible implications for role as tumor suppressor gene. Oncogene 1997; 15: 403-7.
17. Tang X, Khuri R, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L. Hypermethylation of the Death-Associated Protein (DAP) kinase promoter and aggressiveness in stage I non-small cell lung cancer. J Natl Cancer Inst 2000; 18: 1511-6.
18. Cohen MM Jr. RUNX genes, neoplasia, and cleidocranial dysplasia. Am J Med Genet 2001; 104: 185-8.
19. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113-24.
20. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-6.
21. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB, Issa JP. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999; 59: 5438-42.
22. Nakagawa H, Nuovo GJ, Zervos EE, Martin EW Jr, Salovaara R, Aaltonen LA, de la Chapelle A. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 2001; 61: 6991-5.
23. Satoh A, Toyota M, Itoh F, Kikuchi T, Obata T, Sasaki Y, Suzuki H, Yawata A, Kusano M, Fujita M, Hosokawa M, Yanagihara K, Tokino T, Imai K. DNA methylation and histone deacetylation associated with silencing DAP-kinase gene expression in colorectal and gastric cancers. Br J Cancer 2002; 86: 1817-23.
24. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 2847-51.
25. Honda T, Tamura G, Waki T, Jin Z, Sato K, Motoyama T, Kimura W, Kawata S, Nishizuka S, Murakami Y. Hypermethylation of TSLCI gene promoter in primary gastric cancers and gastric cancer cell lines. Jpn J Cancer Res 2002; 93: 857-60.